is bitcoin the future of money, Knowledge

The European Central Bank opened the door for further interest rate cuts. On Thursday, the European Central Bank cut interest rates for the fourth time this year and opened the door for further interest rate cuts in the future, because inflation is close to its target and the economy is still weak. The European Central Bank lowered the deposit interest rate from 3.25% to 3.0%, and cancelled the statement that the interest rate remained "sufficiently restrictive", suggesting that it was possible to cut interest rates further. The European Central Bank said: "The financial environment is easing, because the recent interest rate cuts by the European Central Bank have gradually reduced the new borrowing costs of enterprises and households." "But the financial environment is still very tight, because monetary policy is still restrictive, and past interest rate hikes are still being transmitted to outstanding stock credit."The Nikkei 225 index just broke through the 40000.00 mark, and the latest report was 40000.43, up 1.60% in the day.Deutsche Bank appointed MARCUS CHROMIK as the new CRO.

European Central Bank: It plans to stop reinvesting in the Emergency Anti-epidemic Bond Purchase Program (PEPP) by the end of 2024. Continue to reduce the emergency anti-epidemic bond purchase program (PEPP) by 7.5 billion euros per month.Traders' interest rate expectations for the European Central Bank remain stable: it is expected to cut interest rates by 127 basis points in 2025.The main fuel contract rose by 6.00% in the day and is now reported at 3249.00 yuan/ton.

The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)In the first ten months, Jiangsu's ship exports exceeded 60%, ranking first in the country. According to Nanjing Customs statistics, from January to October this year, Jiangsu exported 85.84 billion yuan of all kinds of ships, ranking first in the country in terms of export scale, with a year-on-year increase of 63.2%. The exports of three main ship types, namely, tankers, container ships and bulk carriers, increased by 179.5%, 91% and 16.2% respectively.Domestic futures opened mixed at night, with Shanghai copper down 0.56%, Shanghai zinc down 0.39%, Shanghai nickel up 1.75%, iron ore up 0.06%, coking coal up 0.42% and crude oil up 1.15%.